Showing 2401-2410 of 4066 results for "".
- Ravulizumab in IgA Nephropathy: Phase 2 Trial Readouthttps://reachmd.com/news/ravulizumab-in-iga-nephropathy-phase-2-trial-readout/2486671/Key Takeaways During the randomized period, ravulizumab was associated with a greater reduction in proteinuria than placebo at week 26 (−41.9% vs −16.8%; treatment effect 30.1%; P = 0.005). Investigators reported a trend toward eGFR stabilization (leas
- AAD 2026: Revance to Showcase Expanding Aesthetics Portfoliohttps://reachmd.com/news/aad-2026-revance-to-showcase-expanding-aesthetics-portfolio/2486383/Revance Therapeutics Inc. announced it will showcase its expanding portfolio of aesthetics, regenerative medicine, and consumer skincare products at the 2026 American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 26–31 in Denver, Colorado. The company plans a series of in-booth
- AAD 2026: Acclaro to Highlight Expanding Clinical Uses of UltraClear 2910 nm Fiber Laserhttps://reachmd.com/news/aad-2026-acclaro-to-highlight-expanding-clinical-uses-of-ultraclear-2910-nm-fiber-laser/2486381/Emerging clinical data on Acclaro’s UltraClear® 2910 nm fiber laser is set to be presented during multiple sessions at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado from March 26 through 31. The technology, a cold ablative fiber lase
- Sanofi to Present Data on Dupilumab for BP, AD, CSU, PN, Plus Amlitelimabhttps://reachmd.com/news/Sanofi-Present-Data-Dupilumab-BP-AD-CSU-PN-Plus-Amlitelimab/2471384/Sanofi will present 26 abstracts, including one late-breaking and five additional oral presentations, across approved and investigational medicines at the American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, from March 7-11. Presentations in partnership with Regeneron
- Influence of First Birth Age on Rheumatoid Arthritis Riskhttps://reachmd.com/news/influence-of-first-birth-age-on-rheumatoid-arthritis-risk/2471091/Quick Summary Research published in PLOS ONE indicates that women who give birth for the first time before 26 or after 35 years of age may have a heightened risk of rheumatoid arthritis. The study utilized data from the NHANES, analyzing 7,449 women, and found speci
- US Measles Cases Are Already Triple Those of Last Yearhttps://reachmd.com/news/us-measles-cases-are-already-triple-those-of-last-year/2467575/by Robin Foster With five months still to go, the number of U.S. measles cases reported so far this year has already triple that of all the cases seen in the country last year, federal health officials report. A total of 188 cases have been confirmed in 26 states and
- C-Path Launches Consortium for Alpha-1 Antitrypsin Deficiencyhttps://reachmd.com/news/c-path-launches-consortium-for-alpha-1-antitrypsin-deficiency/2462474/TUCSON, Ariz., March 26, 2024 — Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) Consortium. The CPA-1 consortium aims to accelerate drug developm
- Machine Learning Models Show High Accuracy in Predicting Pediatric Sepsis Within 48 Hours of ED Visithttps://reachmd.com/news/machine-learning-models-show-high-accuracy-in-predicting-pediatric-sepsis-within-48-hours-of-ed-visit/2483960/A new study published in JAMA Pediatrics reports the successful development and validation of machine‑learning models that estimate a child’s risk of developing sepsis—or
- The Role of Moderate Weight Loss in Reversing Type 2 Diabetes: Latest Insights and Implicationshttps://reachmd.com/news/the-role-of-moderate-weight-loss-in-reversing-type-2-diabetes-latest-insights-and-implications/2471356/Emerging research highlights the potential of moderate weight loss and lifestyle interventions to reverse type 2 diabetes by improving insulin sensitivity and reducing intrahepatic lipid content. Understanding the Mechanism of Reversal
- Large Study Offers Latest Insights into After-Effects of Severe COVID-19 on the Brainhttps://reachmd.com/news/large-study-offers-latest-insights-into-after-effects-of-severe-covid-19-on-the-brain/2468271/Credit: Pixabay/CC0 Public Domain In the U.K.'s largest study to date, researchers have come to a better understanding of th